The import of sulphonamides to China is projected to increase from 3.5214 million kilograms in 2024 to 3.939 million kilograms in 2028. This showcases a steady year-on-year growth in import volumes. Assuming that imports stood at approximately 3.415 million kilograms in 2023, there is an observable positive growth trend over these forecasted years, highlighting a continuous demand for sulphonamides in China. This growth translates to a compound annual growth rate (CAGR) of roughly 2.8% over the five-year forecast period from 2024 to 2028.
Future trends to watch include potential changes in regulatory frameworks, developments in domestic production capacities, and variations in global supply chain dynamics that could affect import levels. Additionally, any shifts in healthcare demands and pharmaceutical consumption in China might further influence these trends.
